Cognition Therapeutics Inc [NASDAQ: CGTX] gained 32.64% on the last trading session, reaching $0.32 price per share at the time.
If compared to the average trading volume of 761.14K shares, CGTX reached a trading volume of 12012330 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Cognition Therapeutics Inc [CGTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CGTX shares is $3.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CGTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
B. Riley Securities have made an estimate for Cognition Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 19, 2024. The new note on the price target was released on July 30, 2024, representing the official price target for Cognition Therapeutics Inc stock. Previously, the target price had yet another raise to $22, while Oppenheimer analysts kept a Outperform rating on CGTX stock.
The Average True Range (ATR) for Cognition Therapeutics Inc is set at 0.04 The Price to Book ratio for the last quarter was 1.60, with the Price to Cash per share for the same quarter was set at 0.26.
Trading performance analysis for CGTX stock
Cognition Therapeutics Inc [CGTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.77. With this latest performance, CGTX shares dropped by -29.11% in over the last four-week period, additionally sinking by -21.63% over the last 6 months – not to mention a drop of -84.54% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CGTX stock in for the last two-week period is set at 47.91, with the RSI for the last a single of trading hit 52.89, and the three-weeks RSI is set at 45.60 for Cognition Therapeutics Inc [CGTX]. The present Moving Average for the last 50 days of trading for this stock 0.3678, while it was recorded at 0.2613 for the last single week of trading, and 0.5128 for the last 200 days.
Cognition Therapeutics Inc [CGTX]: A deeper dive into fundamental analysis
Cognition Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.09 and a Current Ratio set at 2.09.
Cognition Therapeutics Inc [CGTX]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CGTX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Cognition Therapeutics Inc go to 32.88%.
An analysis of Institutional ownership at Cognition Therapeutics Inc [CGTX]
The top three institutional holders of CGTX stocks are: VANGUARD GROUP INC with ownership of 1.15 million shares, which is approximately 2.8644%. AWM INVESTMENT COMPANY, INC., holding 0.65 million shares of the stock with an approximate value of $$1.08 million in CGTX stocks shares; and AWM INVESTMENT COMPANY, INC., currently with $$0.83 million in CGTX stock with ownership which is approximately 1.248%.
